Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/LOVE stock hub

TSX/LOVE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TSX/LOVEis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
173.9M
Toronto Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TSX/LOVE
In the news

Latest news · TSX/LOVE

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.4
P25 11P50 15.6P75 25.4
Trailing P/E16.2
P25 7.4P50 15.6P75 34.3
ROE9.5
P25 -121.5P50 -40.9P75 0.5
ROIC9.1
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TSX/LOVE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
212
Groups with data
11
Currency
CAD
Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Canada
Country code
CA
Employees
452
Employees Change
89%
Employees Change Percent
24.52
Enterprise value
CAD 186.2M
Exchange
Toronto Stock Exchange
Financial currency
CAD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Last refreshed
2026-05-10
Market cap
CAD 173.9M
Price
CAD 1.76
Price currency
CAD
Rev Per Employee
250,032.91x
Sector
Healthcare
Sic
2834
Symbol
tsx/LOVE
Website
https://cannara.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
5.84%
EV Earnings
18.33x
EV/EBIT
10.44x
EV/EBITDA
7.69x
EV/FCF
11.55x
EV/Sales
1.65x
FCF yield
9.27%
Forward P/E
11.35x
P/B ratio
1.45x
P/E ratio
16.19x
P/S ratio
1.54x
PE Ratio3 Y
12.47x
PE Ratio5 Y
30.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
15.78%
EBITDA Margin
21.18%
FCF margin
14.26%
Gross margin
42.47%
Gross Profit
CAD 48M
Gross Profit Growth
21.89%
Gross Profit Growth Q
-1.81%
Gross Profit Growth3 Y
32.72%
Gross Profit Growth5 Y
91.74%
Net Income
CAD 10.2M
Net Income Growth
-24.18%
Net Income Growth Q
-49.84%
Net Income Growth Years
1%
Net Income Growth3 Y
44.5%
Pretax Margin
13.44%
Profit Margin
8.99%
Profit Per Employee
CAD 22,473
Profitable Years
4
ROA
6.49
Roa5y
3.98
ROCE
11.73
ROE
9.48
Roe5y
6.29
ROIC
9.1
Roic5y
6.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

15
MetricValue
Cagr1y
35.41%
Cagr3y
28.99%
Cagr5y
3.95%
EPS Growth
-21.69
EPS Growth Q
-52.86
EPS Growth Years
1
EPS Growth3 Y
41.58
FCF Growth
255.34%
OCF Growth
156%
Revenue Growth
20.14x
Revenue Growth Q
2.6x
Revenue Growth Quarters
25x
Revenue Growth Years
7x
Revenue Growth3 Y
35.98x
Revenue Growth5 Y
86.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
CAD 0.66
Assets
CAD 181.8M
Cash
CAD 21.9M
Current Assets
CAD 91.1M
Current Liabilities
CAD 29.8M
Debt
CAD 34.2M
Debt EBITDA
CAD 1.41
Debt Equity
CAD 0.28
Debt FCF
CAD 2.12
Equity
CAD 120.2M
Interest Coverage
6.33
Liabilities
CAD 61.6M
Long Term Assets
CAD 90.7M
Long Term Liabilities
CAD 31.8M
Net Cash
CAD -12.3M
Net Cash By Market Cap
CAD -7.09
Net Debt EBITDA
CAD 0.51
Net Debt Equity
CAD 0.1
Net Debt FCF
CAD 0.76
Tangible Book Value
CAD 120.2M
Tangible Book Value Per Share
CAD 1.22
WACC
6.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.06
Inventory Turnover
1.31
Net Working Capital
CAD 48.4M
Quick ratio
1.15
Working Capital
CAD 61.3M
Working Capital Turnover
CAD 2.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
35.39%
200-day SMA
1.79
3Y total return
114.63%
50-day SMA
1.82
50-day SMA vs 200-day SMA
50over200
5Y total return
21.38%
All Time High
3.45
All Time High Change
-48.99%
All Time High Date
2019-01-14
All Time Low
0.5
All Time Low Change
252%
All Time Low Date
2019-07-08
ATR
0.07
Beta
0.38
Beta1y
0.25
Beta2y
0.31
Ch YTD
1.15
High
1.8
High52
2.07
High52 Date
2026-01-26
High52ch
-14.98%
Low
1.74
Low52
1.08
Low52 Date
2025-06-11
Low52ch
62.96%
Ma50ch
-3.4%
Price vs 200-day SMA
-1.46%
RSI
44.66
RSI Monthly
64.14
RSI Weekly
48.98
Sharpe ratio
0.84x
Sortino ratio
1.47
Total Return
-3%
Tr YTD
1.15
Tr1m
-4.86%
Tr1w
-1.12%
Tr3m
-5.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
CAD 17.8M
Operating Income Growth
10.71
Operating Income Growth Q
-41.42
Operating Income Growth3 Y
38.32
Operating margin
15.78

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
45,500,964%
Net Borrowing
-3,633,549
Shares Insiders
3.92%
Shares Institutions
0.25%
Shares Out
98,782,148
Shares Qo Q
2.33%
Shares Yo Y
3%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
CAD 12.7M
Average Volume
69,618.4x
Bv Per Share
1.22
CAPEX
CAD -11.5M
Ch1m
-4.86
Ch1w
-1.12
Ch1y
35.39
Ch3m
-5.38
Ch3y
114.6
Ch5y
21.38
Ch6m
7.98
Change
-1.12%
Change From Open
-1.12
Close
1.78
Days Gap
0
Depreciation Amortization
6,111,571
Dollar Volume
104,306.4
Earnings Date
2026-04-14
EBIT
CAD 17.8M
EBITDA
CAD 23.9M
EPS
CAD 0.11
F Score
8
FCF
CAD 16.1M
FCF EV Yield
8.65x
FCF Per Share
CAD 0.16
Financing CF
153,561
Fiscal Year End
August
Founded
2,017
Graham Number
1.7254
Graham Upside
-1.97
Income Tax
CAD 5M
Investing CF
-10,944,781
Is Primary Listing
1
Last Earnings Date
2026-04-14
Last Report Date
2026-02-28
Last Split Date
2023-02-13
Last Split Type
Reverse
Lynch Fair Value
CAD 2.72
Lynch Upside
54.44
Ma150
1.78
Ma150ch
-1.07%
Ma20
1.8
Ma20ch
-2.22%
Net CF
16,847,062
Next Earnings Date
2026-07-20
Open
1.78
P FCF Ratio
10.79
P OCF Ratio
6.29
Position In Range
33.33
Ppne
89,867,712
Price Date
2026-05-08
Price EBITDA
CAD 7.26
Ptbv Ratio
1.45
Relative Volume
0.88x
Revenue
113,014,875x
SBC By Revenue
3x
Share Based Comp
3,388,279
Tax By Revenue
4.46x
Tax Rate
33.15%
Tr6m
7.98%
Volume
59,265
Z Score
2.84
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TSX/LOVE pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/LOVE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+35.4%
S&P 500 1Y: n/a
3Y total return
+114.6%
S&P 500 3Y: n/a
5Y total return
+21.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TSX/LOVE?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.3%
Share of float held by funds and institutions
Insider ownership
+3.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+3.0%
Negative means the company is buying back shares.
Technical

TSX/LOVE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.7
Neutral momentum band
Price vs 200-day MA
-1.5%
50/200-day relationship not available
Beta (5Y)
0.38
Less volatile than the market
Sharpe ratio
0.84
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TSX/LOVE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/LOVE stock rating?

tsx/LOVE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/LOVE analysis?

The full report lives at /stocks/tsx/LOVE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/LOVE?

The latest report frames tsx/LOVE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/LOVE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.